Tower Research Capital »

Liminatus Pharma Inc A shares owned by Tower Research Capital

Quarter-by-quarter ownership of Liminatus Pharma Inc A (LIMN) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Liminatus Pharma Inc A

Tip: Access up to 7 years of quarterly data

All positions including Liminatus Pharma Inc A held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liminatus Pharma Inc A by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.1k 1.8k 1.67
2025-06-30 $5.7k 508 11.15

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Liminatus Pharma Inc A

Vanguard Group
Geode Capital Management
UBS Group
Jane Street
State Street Corporation
BlackRock
Squarepoint Ops
Tower Research Capital
Farther Finance Advisors

View all funds holding Liminatus Pharma Inc A